346: Zealand's obesity strategy and Immunovant's curious development plan
The Readout Loud
00:00
Intro
This chapter explores the dynamic changes in the biotechnology industry, spotlighting Zealand Pharma's new obesity treatment and its collaboration with Roche. Additionally, it presents key updates from ImmuneVent and important discussions from a recent summit in New York.
Transcript
Play full episode
